🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized pilot phase II trial studies how well vaccine therapy works...
Status
Completed
Location
Providence Portland Medical Center
Start Date
1999-04
Trial ID
NCT00003895
Treatments Being Tested
The goal of this clinical research study is to learn if the drug leuprolide...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-11
Trial ID
NCT00254397
Treatments Being Tested
This randomized phase II trial is studying how well giving vaccine therapy ...
Status
Terminated
Location
National Cancer Institute Surgery Branch
Start Date
2005-11
Trial ID
NCT00303836
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Surgery Branch
Start Date
2001-02
Trial ID
NCT00020475
Treatments Being Tested
This is a pilot trial to investigate the use of GM-CSF DNA as an adjuvant f...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-12
Trial ID
NCT00580060
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in differe...
Status
Completed
Location
Providence Cancer Center at Providence Portland Medical Center
Start Date
2004-07
Trial ID
NCT00091143
RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
2003-10
Trial ID
NCT00334776
This phase I/II study is directed at evaluating safety and immunogenicity o...
Status
Completed
Location
University Hospital Tor Vergata
Start Date
2004-09
Trial ID
NCT00559026
Treatments Being Tested
This randomized phase III trial studies aldesleukin with vaccine therapy to...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
1999-12
Trial ID
NCT00019682
RATIONALE: Vaccines made from peptides may help the body build an effective...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2008-10
Trial ID
NCT00471471
Treatments Being Tested